• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'receptor tyrosine kinase'

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen

• Tyrosine-Kinase Associated Receptors: receptors that associate with proteins that have tyrosine kinase activity (Cytokine Receptors).. Receptor

Protected

N/A

18
0
0
2022
Investigating the role of plasma membrane phosphoinositides in the regulation of the plasma membrane localization and function of Ras proteins

PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 are well-known signaling molecules in G- protein coupled receptor and receptor tyrosine kinase pathways, but beside their

Protected

N/A

21
0
0
2022
Tumor distribution and efficacy of antiangiogenic receptor tyrosine kinase inhibitors

Binding the growth factor leads to the activation of signaling cascades, influencing the survival, proliferation and migration of endothelial cells and thus the maintenance

Protected

N/A

149
0
0
2022
Az angiogén faktorok szerepe praeeclampsiában

Flk = fetal liver kinase; Flt = fms-like tyrosine kinase; PDGF = vérlemezke-eredetű növekedési faktor; PlGF = placentáris nö- vekedési faktor; sFlt = soluble fms-like tyrosine

Protected

N/A

7
0
0
2022
Partial rescueofgeldanamycin-inducedTrkA depletion by a proteasome inhibitor in PC12 cells

DMSO, dimethyl-sulfoxyde; EDTA, ethylenediaminetetraacetic acid; EGTA, ethylene glycol tetraacetic acid; ErbB2, an oncogenic receptor tyrosine kinase, analogous to Her2/neu;

Protected

N/A

10
0
0
2022
Molecular testing in lung cancer in the era of precision medicine

When epidermal growth factor receptor (EGFR) mutation was detected in patients with pulmonary adenocarcinomas and subsequent specific treatment with tyrosine kinase inhibitors

Protected

N/A

10
0
0
2022
Az onkohematológiai betegségek kezelésében használt tirozinkináz-gátló imatinib és nilotinib csonthatásainak irodalmi áttekintése és a saját kutatási eredmények bemutatása

Tyrosine kinase inhibitors are widely used for treatment of certain oncohematological diseases. Several clinical studies have confirmed that specific BCR-ABL tyrosine kinase

Protected

N/A

9
0
0
2022
Myeloproliferatív megbetegedések  hátterében szereplő új patogenomikai részletek megismerése

2012 Vienna, Austria : A patient with idiopathic hypereosinophilic syndrome reacting to a tyrosine-kinase inhibitor- How long should such a patient receive tyrosine kinase

Protected

N/A

10
0
0
2022
Novel kinase inhibitor compounds for combination cancer therapy

(2013) Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.. Tanizaki

Protected

N/A

128
0
0
2022
Tumor distribution and efficacy of antiangiogenic receptor tyrosine kinase inhibitors Ph.D. Thesis

In the absence of selective HIF inhibitors and the presence of a number of factors that also regulate the expression of angiogenic cytokines in tumors,

Protected

N/A

20
0
0
2022
Angiogenesis and angiogenic tyrosine-kinase receptor and claudin-5 expression in pediatric brain tumors

Angiogenic tyrosine kinase receptor patterns specific to each tumor type were found in the blood vessels of the brain tumors; most VEGFR2 and c-Kit positive vessels

Protected

N/A

17
0
0
2022
EPIDEMIOLOGY AND CLINICAL RELEVANCE OF SUBTYPE-SPECIFIC KRAS AND EGFR MUTATIONS IN LUNG ADENOCARCINOMA

(2012) Rare and complex mutations of epidermal growth factor receptor (EGFR) and efficacy of tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer

Protected

N/A

109
0
0
2022
Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors:

A positive correlation between a low basal phosphorylation of AKT S473 and the induction of HER3 phosphorylation was evident as 7 of 10 cell lines with low pAKT S473 levels, but only

Protected

N/A

18
0
0
2022
AZ ÍROTT NYELV ÉS A NYELVTANÍRÓK SZEREPE EGY STABIL VÁLTAKOZÁS FÖNNTARTÁSÁBAN

Az írott nyelv felhőrégiói azonban sokáig nem voltak szoros kapcsolatban a mindennapok beszélt nyelvével, az „elparasztúlt” (Geleji) szóbeliséggel. Ha ekkor és a

Protected

N/A

8
0
0
2022
Stable manifolds for non-instantaneous impulsive nonautonomous differential equations

The notion of nonuniform hyperbolicity plays an important role in the construction of stable and unstable invariant manifolds and we establish a stable invariant manifold result

Protected

N/A

28
0
0
2022
Signal transduction TÁMOP-4.1.2-08/1/A-2009-0011 1

Tyrosine kinase-linked receptors I.: Cytokine/chemokine signaling (Title).. Characteristics of multichain cytokine receptors

Protected

N/A

9
0
0
2022
John Wiley felvásárolja a Blackwellt megtekintése

A Blackwell tudományos kiadó tervezett felvásár- lása a rivális John Wiley (USA) által, széles kör ű ellenállásba ütközött a könyvtárak és egyetemek részér ő

Protected

N/A

1
0
0
2022
Elastic alpha scattering experiment on 64Zn

Low energy alpha-nucleus optical potentials are an important ingredient of reaction cross sec- tion calculations relevant in various processes of heavy element nucleosynthesis, such

Protected

N/A

1
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!